Amgen Inc (AMGN)
AMGEN TO PRESENT AT GOLDMAN SACHS 46TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
Intellia Therapeutics Inc (NTLA)
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Syndax Pharmaceuticals Inc (SNDX)
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Adverum Biotechnologies Inc (ADVM)
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
9 Meters Biopharma, Inc. (NMTRQ)
Early Reviews of the Switch 2 Highlight Significant Hardware Improvements
Corcept Therapeutics Incorporated (CORT)
Corcept stelt de resultaten voor van de Fase 2-studie van dazucorilant bij patiënten met ALS (amyotrofe laterale sclerose) tijdens de jaarlijkse bijeenkomst van de ENCALS 2025
Corcept Therapeutics Incorporated (CORT)
Corcept präsentiert Ergebnisse der Phase-2-Studie mit Dazucorilant bei Patienten mit amyotropher Lateralsklerose (ALS) auf der ENCALS-Jahrestagung 2025
Corcept Therapeutics Incorporated (CORT)
Corcept présente les résultats dune étude de phase 2 évaluant le dazucorilant chez les patients atteints de sclérose latérale amyotrophique (SLA) lors de la réunion annuelle 2025 de lENCALS
9 Meters Biopharma, Inc. (NMTRQ)
Intel Arc Battlemage: What’s Next for the Lineup
Fortrea Holdings Inc (FTRE)
Deadline Approaching: Fortrea Holdings Inc. (FTRE) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith